# FDA Warning Letter: Hybrid Pharma, LLC
> 2022-06-14 · Office of Pharmaceutical Quality Operations, Division II · `0cb6cd9f6886beff`
## Letter
- **Company:** Hybrid Pharma, LLC
- **Posted Date:** 2022-06-14
- **Letter Issue Date:** 2022-06-07
- **Issuing Office:** Office of Pharmaceutical Quality Operations, Division II
## Subject
Compounding Pharmacy/Adulterated Drug Products
---
*Source: [FDA Warning Letters](https://www.fda.gov/inspections-compliance-enforcement-and-criminal-investigations/compliance-actions-and-activities/warning-letters) · AI Analytics · CC0 1.0*